We are live on ! Find out more
BHCM

Brevan Howard Capital Management Portfolio holdings

AUM $11.3B
1-Year Est. Return 35.84%
This Fund
S&P 500
This Quarter Est. Return
+11.38%
1 Year Est. Return
+35.84%
3 Year Est. Return
+106.49%
5 Year Est. Return
+80.14%
10 Year Est. Return
AUM
$8.18B
AUM Growth
+$422M
Cap. Flow
-$70.2M
Cap. Flow %
-0.86%
Top 10 Hldgs %
80.21%
Holding
1,125
New
743
Increased
197
Reduced
52
Closed
119

Sector Composition

Rank Sector Weight
1 Technology 1.72%
2 Industrials 1.29%
3 Consumer Discretionary 1.28%
4 Financials 1.01%
5 Healthcare 0.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TTI icon
976
TETRA Technologies
TTI
$1.26B
$64K ﹤0.01%
+14,170
New +$71.5K
NXDR
977
Nextdoor Holdings
NXDR
$986M
$62.8K ﹤0.01%
+33,210
New +$58.6K
BKCC
978
DELISTED
BlackRock Capital Investment Corporation
BKCC
$61.2K ﹤0.01%
+15,818
New +$57.6K
CVAC
979
DELISTED
CureVac
CVAC
$59.4K ﹤0.01%
+14,105
New +$76.5K
RMNI icon
980
Rimini Street
RMNI
$471M
$55.9K ﹤0.01%
+17,104
New +$47K
WTI icon
981
W&T Offshore
WTI
$518M
$55.5K ﹤0.01%
+17,030
New +$62.8K
PGY icon
982
Pagaya Technologies
PGY
$1.78B
$52.3K ﹤0.01%
+3,157
New +$51.5K
LYEL icon
983
Lyell Immunopharma
LYEL
$360M
$50.6K ﹤0.01%
+1,305
New +$47K
NUVB icon
984
Nuvation Bio
NUVB
$2.32B
$49.4K ﹤0.01%
+32,723
New +$42.1K
EVC icon
985
Entravision Communication
EVC
$1.1B
$47K ﹤0.01%
+11,278
New +$44.6K
RBBN icon
986
Ribbon Communications
RBBN
$383M
$45.6K ﹤0.01%
+15,724
New +$35.4K
ABUS icon
987
Arbutus Biopharma
ABUS
$915M
$44.4K ﹤0.01%
+17,759
New +$34.8K
COOK icon
988
Traeger
COOK
$172M
$41.9K ﹤0.01%
+307
New +$39.6K
ALTO icon
989
Alto Ingredients
ALTO
$340M
$41.5K ﹤0.01%
+15,602
New +$49.7K
AMWL icon
990
American Well
AMWL
$230M
$32.2K ﹤0.01%
+1,079
New +$26.5K
MYPS icon
991
PLAYSTUDIOS Inc
MYPS
$90.1M
$29.6K ﹤0.01%
+10,932
New +$29.8K
EXK
992
Endeavour Silver
EXK
$2.83B
$29.5K ﹤0.01%
+14,971
New +$32.5K
MVST icon
993
Microvast
MVST
$302M
$24.2K ﹤0.01%
17,299
-1,209
-7% -$1.62K
GEVO icon
994
Gevo
GEVO
$382M
$16.2K ﹤0.01%
13,949
-3,324
-19% -$3.79K
RIGL icon
995
Rigel Pharmaceuticals
RIGL
$750M
$15K ﹤0.01%
+1,037
New +$10.6K
ABNB icon
996
Airbnb
ABNB
$107B
-2,780
Closed -$381K
ABNB icon
997
PUT
Airbnb
ABNB
$107B
-45,000
Closed -$6.17M
ADBE icon
998
Adobe
ADBE
$105B
-991
Closed -$505K
ADM icon
999
Archer Daniels Midland
ADM
$36.9B
-5,102
Closed -$385K
ADNT icon
1000
Adient
ADNT
$1.5B
-10,934
Closed -$401K

Similar funds

Brevan Howard Capital Management's Q4 2023 Portfolio in Review

As of Q4 2023, Brevan Howard Capital Management held 1,125 positions worth $8.18B, up 5.4% from $7.76B the previous quarter. Its ten largest holdings account for 80% of the portfolio.

Brevan Howard Capital Management's Q4 2023 filing shows 743 new, 197 increased, 52 reduced and 119 closed positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 500,000 shares worth $38.7M. The largest sale was iShares MSCI Brazil ETF, an estimated $30.8M.

By sector, the portfolio is most concentrated in Technology at 1.7% of assets, up from 0.48% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • Brevan Howard Capital Management's largest Q4 2023 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 500,000 shares worth $38.7M.
  • Brevan Howard Capital Management added most to iShares JPMorgan USD Emerging Markets Bond ETF in Q4 2023, an estimated $95.9M increase.
  • Brevan Howard Capital Management's biggest Q4 2023 reduction was iShares MSCI Brazil ETF, cutting an estimated $30.8M.
  • Brevan Howard Capital Management fully exited CME Group in Q4 2023, selling an estimated $20.5M.
  • Brevan Howard Capital Management's ten largest holdings make up 80% of its $8.18B portfolio in Q4 2023.
  • Brevan Howard Capital Management opened 743 new positions and closed 119 in Q4 2023.
  • Brevan Howard Capital Management's portfolio value rose 5.4% quarter-over-quarter to $8.18B.

Based on Brevan Howard Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.